Guidance

Breast screening: clinical guidelines for screening assessment

• From: Public Health England
• Part of: Breast screening: professional guidance
• Published: 1 June 2010
• Last updated: 15 November 2016, see all updates

NHSBSP Publication No 49: clinical guidelines for healthcare professionals screening women for breast cancer.

Documents

Clinical guidelines for breast cancer screening assessment: fourth edition

Ref: NHSBSP Publication No 49; PHE publications gateway number: 2016426 PDF, 510KB, 36 pages

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The aim of assessment is to obtain a definitive and timely diagnosis of all potential abnormalities detected during screening.

This is best achieved by using ‘triple assessment’, comprising:

• imaging (usually mammography and ultrasound)
• clinical examination
• image guided needle biopsy for histological examination if indicated

Cytology should no longer be used alone to obtain a non-operative diagnosis of breast cancer.

Document information

Published: 1 June 2010

Updated: 15 November 2016

+ full page history

1. 15 November 2016 Updated with new 2016 clinical guidance.
2. 1 June 2010 First published.

From: Public Health England

Part of: Breast screening: professional guidance